These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 35230508

  • 1. Perfusion analysis of benign parotid gland tumors by contrast-enhanced ultrasonography (CEUS).
    Welkoborsky HJ, Albers M, Küstermeyer J.
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4137-4146. PubMed ID: 35230508
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differentiation of parotid gland tumors with contrast-enhanced ultrasound.
    Fischer T, Paschen CF, Slowinski T, Alkhameri A, Berl JC, Klingebiel R, Thomas A.
    Rofo; 2010 Feb; 182(2):155-62. PubMed ID: 19862655
    [Abstract] [Full Text] [Related]

  • 8. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
    Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L, Nemec SF, Mueller-Mang C, Weber M, Mayerhoefer ME.
    NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Analysis of Perfusion Parameters within Salivary Gland Tumors using Contrast Enhanced Ultrasound].
    Küstermeyer J, Klingelhöfer G, Welkoborsky HJ.
    Laryngorhinootologie; 2016 Oct; 95(10):688-693. PubMed ID: 26925572
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of pleomorphic adenomas, adenolymphomas, and malignant tumors of the salivary glands on color doppler ultrasonography and contrast enhanced ultrasonography.
    Jiang LP.
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11509-11517. PubMed ID: 33275217
    [Abstract] [Full Text] [Related]

  • 12. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
    Mikaszewski B, Markiet K, Smugała A, Stodulski D, Szurowska E, Stankiewicz C.
    Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Perfusion characteristics of parotid gland tumors evaluated by contrast-enhanced ultrasound.
    Klotz LV, Gürkov R, Eichhorn ME, Siedek V, Krause E, Jauch KW, Reiser MF, Clevert DA.
    Eur J Radiol; 2013 Dec; 82(12):2227-32. PubMed ID: 24029161
    [Abstract] [Full Text] [Related]

  • 19. Quantitative diagnosis of salivary gland tumors with contrast-enhanced ultrasound--a preliminary study.
    Gou JM, Chen Q, Zhou Q, Liu YX.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Dec; 116(6):784-90. PubMed ID: 24209995
    [Abstract] [Full Text] [Related]

  • 20. Multimodal Ultrasonographic Pathway of Parotid Gland Lesions.
    Mansour N, Bas M, Stock KF, Strassen U, Hofauer B, Knopf A.
    Ultraschall Med; 2017 Apr; 38(2):166-173. PubMed ID: 26274381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.